Laboratorio de Biología Molecular y Virología, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Km 4.5 Carretera Atlixco-Metepec, CP 74360 Metepec, Puebla, México.
Virol J. 2010 Sep 18;7:243. doi: 10.1186/1743-422X-7-243.
Interferon (IFN)-α receptor 1 (ifnar1) and suppressor of cytokine signaling 1 (socs1) transcription levels were quantified in peripheral blood mononuclear cells (PBMC) of 59 patients infected with hepatitis C virus (HCV) and 17 non-infected individuals. Samples were obtained from patients infected with HCV that were either untreated or treated with IFN-α2 plus ribavirin for 1 year and divided into responders and non-responders based on viral load reduction 6 months after treatment. Ifnar1 and socs1 transcription was quantified by real-time RT-PCR, and the fold difference (2(⁻ΔΔCT)) with respect to hprt housekeeping gene was calculated.
Ifnar1 transcription increased significantly in HCV-infected patients either untreated (3.26 ± 0.31), responders (3.1 ± 0.23) and non-responders (2.18 ± 0.23) with respect to non-infected individuals (1 ± 0.34; P = 0.005). Ifnar1 transcription increased significantly (P = 0.003) in patients infected with HCV genotypes 1a (4.74 ± 0.25) and 1b (2.81 ± 0.25) but not in 1a1b (1.58 ± 0.21). No association was found of Ifnar1 transcription with disease progress, initial viral load or other clinical factors. With respect to socs1 transcription, values were similar for non-infected individuals (1 ± 0.28) and untreated patients (0.99 ± 0.41) but increased in responders (2.81 ± 0.17) and non-responder patients (1.67 ± 0.41). Difference between responder and non-responder patients was not statistically significant. Socs1 transcription increased in patients infected with HCV genotypes 1a and 1b (2.87 ± 0.45 and 2.22 ± 0.17, respectively) but not in 1a1b (1.28 ± 0.40). Socs1 transcript was absent in three patients infected with HCV genotype 1b. A weak correlation between ifnar1 and socs1 transcription was found, when Spearman's correlation coefficient was calculated.
Our results suggest that HCV infection may up-regulate ifnar1 transcription. HCV genotypes differ in their capacity to affect ifnar1 and socs1 transcription, as well as in the ability to evade the antiviral response.
在 59 名丙型肝炎病毒(HCV)感染者和 17 名非感染者的外周血单个核细胞(PBMC)中定量检测干扰素(IFN)-α受体 1(ifnar1)和细胞因子信号转导抑制因子 1(socs1)的转录水平。从感染 HCV 的患者中获得样本,这些患者未经治疗或用 IFN-α2 加利巴韦林治疗 1 年,并根据治疗后 6 个月病毒载量降低将其分为应答者和无应答者。通过实时 RT-PCR 定量检测 ifnar1 和 socs1 转录,并用 hprt 管家基因计算相对于 2(-ΔΔCT)的倍数差异。
与未感染个体(1 ± 0.34;P = 0.005)相比,未治疗的 HCV 感染者(3.26 ± 0.31)、应答者(3.1 ± 0.23)和无应答者(2.18 ± 0.23)的 ifnar1 转录显著增加。HCV 基因型 1a(4.74 ± 0.25)和 1b(2.81 ± 0.25)感染者的 ifnar1 转录显著增加(P = 0.003),但 1a1b 感染者则不然(1.58 ± 0.21)。ifnar1 转录与疾病进展、初始病毒载量或其他临床因素无关。关于 socs1 转录,未感染个体(1 ± 0.28)和未治疗患者(0.99 ± 0.41)的值相似,但应答者(2.81 ± 0.17)和无应答者患者(1.67 ± 0.41)的值增加。应答者和无应答者之间的差异无统计学意义。HCV 基因型 1a 和 1b 感染者的 socs1 转录增加(分别为 2.87 ± 0.45 和 2.22 ± 0.17),但 1a1b 感染者则不然(1.28 ± 0.40)。HCV 基因型 1b 感染者中有 3 例 socs1 转录缺失。当计算 Spearman 相关系数时,发现 ifnar1 和 socs1 转录之间存在弱相关性。
我们的结果表明,HCV 感染可能上调 ifnar1 转录。HCV 基因型在影响 ifnar1 和 socs1 转录的能力以及逃避抗病毒反应的能力方面存在差异。